Epic Test Code LAB549 Hepatitis B Core IgM Anitbody
Performing Location(s)
BMC
Specimen Type
Serum
Preferred Container
Gold or Red top
Blood Tube Draw Volume
Min 50% draw volume
Minimum Volume to Submit for Testing
2 mL Serum
- Multiple test can be performed from this volume. For question please contact the lab at 607-547-3975.
Storage Requirements
Primary specimen tubes should be centrifuged within 2 hours of collection followed by transfer of the serum (red or gold top) to a labeled plastic, aliquot tube.
See Causes of Rejection for temperature requirements.
Transportation Needs
Deliver specimen to laboratory within 1 hour of collection if unspun. If not possible see "storage Requirements".
Causes for Rejection
Mislabeled or unlabeled specimen
Less than 50% draw for Vacutainer tubes
Plasma
Spun or Unspun sample >7 days at 2-8 °C
Spun or Unspun sample >3 days at Room Temperature
Hemolysis > 500 mg/dL HgB
Lipemia > 3000 mg/dL Trig
Bilirubin > 20 mg/dL Bili
Total Protein >12 g/dL
NaF, Citrate, Oxalate
Limitations
Individual with negative results are presume not be immune to HBV infection. This will distinguish rapidly rising anti-HBc IgM levels associated with early acute infection from gradually decreasing or unchanging levels often associated with late acute stage HBV infection, 6-9 months from appearance of HBsAG.
This test cannot determine a patient immune status to HBV.
Specimens from patients with high IgM levels (e.g. Multiple myeloma) may show depressed values.
Specimens from patient who have received mouse monoclonal antibodies (HAMA) for diagnosis or therapy may exhibit either falsely elevated or depressed levels.
Hydrophobic antibodies in human serum may interfere, and additional info may be needed for specimens from patients with Non-Hodgkin’s Lymphoma.
Performance characteristics have not been established for immunocompromised or immunosuppressed patients.
Reference Values
Hepatitis B Core Antibody (Total) Reference Range | ||
Population | Units | Reference Range |
All populations | S/CO | Negative |
Interpretation
A negative result does not exclude the possibility of exposure or infection to HBV.
An equivocal result indicates that IgM antibodies to HBC may or may not be present. Patients should be retested at approximately 1 week intervals if clinically indicated. This will distinguish rapidly rising anti-HBc IgM levels associated with early acute infection from gradually decreasing or unchanging levels often associated with late acute stage HBV infection, 6-9 months from appearance of HBsAG.
A positive e result is presumptive evidence of anti-HBc IgM antibodies.
Days of Analysis
M-F only.
Available STAT
No
Additional Information
This test is not available on a STAT basis or off-hours, weekends or holidays. If an emergency request is necessary, call 3731 for availability. Pathologist approval may be required.
Neonatal serum is acceptable.
Methodology
Two Step Chemilumimetric Immunoassay
CPT Code
86705
Last Updated
3-Oct-22 BHD